Healthcare Industry Insights: August 2022

Tuesday 30 August 2022

Dental Bone Grafts And Substitutes Market $1.42 Billion By 2030

The global Dental Bone Grafts And Substitutes Market size is expected to reach USD 1.42 billion by 2030, registering a CAGR of 9.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing number of dental implant surgeries, the growing target population, technological advancement in synthetic bone grafts, and new product launches are the major growth propelling factors for the market.

According to the Population Reference Bureau 2018 statistics, by 2050, from 13 countries to around 82 countries across the world are anticipated to have more than 20% of the geriatric population (65 years and above). Thus, perpetual growth in the population aged 60 years and above is anticipated to result in an increased prevalence of periodontal diseases. These aforementioned factors are driving the market.

Moreover, the rising adoption of synthetic bone grafts over autografts and allografts due to advantages such as lesser chances of disease transmission, and better acceptance is further propelling the market. Moreover, growing medical tourism in developing countries, as well as a growing number of periodontists and oral surgeons, are some other factors propelling growth. Countries such as South Korea, India, and Turkey are constantly gaining popularity in dental tourism due to cheaper costs and advanced treatment options.

The onset of the pandemic significantly affected the sales of dental bone graft products as almost all the dental services were halted for a major part of 2020. However, as control measures and vaccines were effectively introduced globally, essential dental treatments and sales of dental products rose to assist in a significant recovery. Many key players in the market have reported high growth for their dental implants and biomaterial products in 2021.

Related Press Release@ Dental Bone Grafts And Substitutes Market Report

Dental Bone Grafts And Substitutes Market Highlights

The synthetic segment is expected to show lucrative growth over the forecast period owing to its better acceptance and lower chance of disease transmission
Socket preservation held the largest share as of 2021 owing to the increasing number of dental implant surgeries and growing concern regarding dental health
The dental clinic segment is expected to show lucrative growth in the forecast period. This is due to the availability of surgeons and advanced treatment options
The Asia Pacific is expected to emerge as the fastest-growing region in this space owing to increase medical tourism and disposable income. Moreover, North America held the largest revenue share due to the increased number of dental implant surgeries in this region

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Inhalation Anesthesia Market Size Worth $2.4 Billion By 2030

The global Inhalation Anesthesia Market size is expected to reach USD 2.4 billion by 2030 and is expected to expand at a CAGR of 9.0% in the forecast period, from 2022 to 2030, according to a new report by Grand View Research, Inc. Inhalation anesthetics offer shorter induction period and recovery time along with better efficacy and lesser adverse effects as compared to other alternatives, thus providing better anesthetic effect during surgical procedures. They also provide excellent control over the duration of anesthesia in the patient. Thus, inhalation anesthesia is being preferred over intravenous anesthesia due to these advantages.

Drugs administered through inhalation anesthesia have a quick onset of action even at low dose as compared to intravenous anesthesia. Using inhalation route for administration helps avoid excessive dosage and keeps the patient’s autonomic functions intact. As these drugs are eliminated via lungs, they have lower chances of accumulation in the body. Hence, they result in lower risk of hepatotoxicity. In addition, drugs administered through inhalation route have limited tolerance and addiction level as compared to other alternatives routes.

With the launch of innovative respiratory products such as AnaConDa (Anaesthetic Conserving Device), administration of inhalation general anesthetic agents such as sevoflurane, isoflurane, & other agents have become easier. Inhalation anesthesia is considered to be the best alternative for patients who are on ventilation for more than 24 hours as it becomes easy to monitor the patient’s health.

Major concern associated with anesthetic gas is that only 5% account for patient use and the rest 95% is released in the atmosphere, which leads to greenhouse effect of these gases. The comparative analysis of sevoflurane, isoflurane, and desflurane based on atmospheric time span and global atmospheric concentrations indicates that desflurane poses a high potential threat for environment.

Related Press Release@ Inhalation Anesthesia Market Report

Inhalation Anesthesia Market Report Highlights

Sevoflurane held the largest market share in 2021 due to the fact that its pharmacokinetics and pharmacodynamics leads to many advantages over other alternate inhaled anesthetic agents available.
Desflurane, alone or in combination with nitrous oxide or other inhalation anesthetic agents is used in various surgical procedures owing to its rapid onset of action and elimination rate; therefore, driving the segment demand.
There have been many complications reported with halothane, for instance, halothane-induced hepatitis; therefore, this anesthetic agent has been discontinued in the majority of the western countries.
North America dominated the market in 2021 due to the high demand for sevoflurane and desflurane in the region. Key companies are also undertaking various strategic initiatives that has led to their high revenue growth in the U.S.
China is the largest economy in Asia Pacific. It is a country with the maximum population in the world, hence having a large patient pool for surgeries. A large number of surgeries being performed along with the presence of a large patient pool is anticipated to boost the market over the forecast period.

About Us:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Friday 26 August 2022

Softgel Capsules Market Report, 2022-2030 | Fuji Capsules Co Ltd., Sirio Pharma, Captek, Patheon, Catalent

The global Softgel Capsules Market size is estimated to reach USD 13.09 billion by 2030 registering a CAGR of 7.9%, according to a new report by Grand View Research, Inc. Softgel capsules are proven to be the choice of formulation for poorly soluble drugs and enhance the absorption time of most drug molecules. Its advantages over tablets and other oral formulations have led to the increased adoption of softgel capsules across the globe. Ease of swallowing, taste masking, improved bioavailability, non-reactive, aesthetically appealing, and longer shelf life are the factors influencing its wide acceptance.

Leading players like Catalent, Eurocaps, and many others, are developing vegan capsules to broaden their vegan consumer base as the softgel capsule segment registers nearly 40% of their overall revenue. Large Pharma companies like Pfizer, Novartis, Bayer, and Procter and Gamble, collaborate with leading Contract Manufacturing Organizations (CMO) to provide cost-effective products in the highly competitive market. Research to develop an oral vaccine to treat respiratory infection caused by the SaRS-CoV-2 virus has fueled the R&D of softgel manufacturers. Additionally, the shift towards a healthier lifestyle and immunity-boosting vitamins, have also surged the softgel market post the outbreak of the COVID-19 pandemic.

Related Press Release@ Softgel Capsules Market Report

Softgel Capsules Market Report Highlights

The gelatin segment accounted for the largest revenue share in 2021 in the type outlook due to its advantages over any other excipient in the excipient industry
Nutraceutical companies held the largest revenue-generating segment by manufacturers, owing to the increasing awareness of health supplements among developing nations and the growing number of production houses, and the surge in sales due to the COVID-19 pandemic
North America held the largest share in the market due to the Improved production technology, presence of major players within the region, and increased expenditure on R&D to widen their product portfolio

List of Key Players in Softgel Capsules Market

· Fuji Capsules Co Ltd

· Sirio Pharma

· Captek

· Patheon

· Catalent

· Eurocaps

· Aenova

· Capsugel

· Procaps Laboratories

· Soft Gel Technologies Inc.

Wednesday 24 August 2022

Kyphoplasty Market Size is Estimated to Witness 5.2% CAGR till 2030

The global Kyphoplasty Market size is expected to reach USD 950.83 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.2% from 2022 to 2030. The increasing geriatric population is a key contributing factor attributable to the market growth during the forecast period. Compression fractures affect many individuals worldwide. Vertebral compression fractures (VCFs) are the most common fracture in osteoporosis patients, affecting approximately 750,000 people every year. The occurrence of this condition gradually rises as people age, with an estimated 40% of women aged 80 and older affected.

During the outbreak of COVID-19, non-emergency procedures have significantly impacted the Kyphoplasty market. As restrictions resulted in delays to a number of procedures. Most nations have elevated restrictions on elective surgery. In April 2020, the North American Spine Society (NASS) released a guidance document comprehensive of clinical considerations and recommendations for surgeries and procedures within the following classes: emergent, urgent, and elective. As a result, it is estimated to drive market growth after the recommencement of surgical procedures at full force.

The COVID-19 pandemic has significantly affected the surgical and clinical practice of spine surgeons across the globe. As per an Asia Pacific Spine Society (APSS) Survey, the COVID-19 pandemic had changed spine surgeons’ clinical practices. The study intended to examine the impact of the pandemic on the clinical practices of spine surgeons within the Asia Pacific region. A total of 222 respondents from 19 nations completed the questionnaire. The study resulted in the mean reduction of clinic volume for all nations was 48.1%. Thus, there was a substantial decrease in the number of surgeries performed in Malaysia, Japan, India, the Philippines, and South Korea.

Kyphoplasty can offer faster pain relief and enhanced functional outcomes compared with conservative treatment. Multiple myeloma, one of the cancer form weaken the bones of the back, which leads to fractures and kyphosis. While continuous sitting and bad posture can be the reason for the development of kyphosis. It develops because sitting puts substantial pressure on the vertebrae, wearing them down.

Increasing demand for minimally invasive surgical procedures, improving health reimbursement, technological advancement in new products, and increasing incidence of osteoporosis are other factors expected to promote the market growth during the forecast period. For instance, in September 2020, Stryker’s SpineJack implantable fracture reduction system received the U.S. Centers for Medicare & Medicaid Services (CMS) new technology add-on payment as part of the 2021 inpatient prospective payment system.

Related Press Release@ Kyphoplasty Market Report

Kyphoplasty Market Report Highlights

Bone access devices segment was the largest revenue-generating segment of the market in 2021 owing to the rising prevalence of spine fractures, back pain
Balloon catheters segment is anticipated to witness lucrative growth. The increasing number of technological advancements with the beginning of next-generation kyphoplasty balloons supports segment growth
On the basis of application, the spinal fractures segment held the largest market share and witnessed lucrative growth over the forecast period. Rising incidences of compressed bones of the spine due to cancer, and trauma has led to the growth of the segment
Osteoporosis segment dominated the overall market in terms of revenue in 2021. The increasing prevalence of osteoporosis is expected to lead the segment to its large market share over the other segment
Hospitals segment held the largest market share in 2021. Technologically-advanced medical devices are being used extensively in hospitals, thus supports in market growth
North America dominated in 2021 due to the presence of established manufacturers and a well-developed reimbursement structure in the region
The market is highly competitive in nature as major players are focusing on the product innovation strategies due to changing needs of surgeons and patients
In May 2020, Medtronic launched its Kyphon Assist Directional Cannula in the U.S. for assisting its other kyphoplasty products for the treatment of vertebral compression fractures caused due to osteoporosis, benign lesions, or cancer. Thereby, expanding its product portfolio

Tuesday 23 August 2022

Unilateral Biportal Endoscopy Market Size is Predicted to Witness 6.4% CAGR till 2030

The global Unilateral Biportal Endoscopy Market size is expected to reach USD 1.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2022 to 2030. Increasing demand for minimally invasive surgeries and the growing awareness of the benefits such as reduced hospitalization, minimal collateral tissue damage, reduced postoperative complications, and faster recovery. Moreover, surgeons and their practices are transitioning from conventional open procedures to robotic assisted and visually advanced endoscopic procedures. Furthermore, technology advancements in the field of spinal endoscopic procedures and minimally invasive surgeries are expected to bolster market growth. For instance, June 2017, Olympus introduced 3D surgical endoscope, which is compatible with VISERA ELITE II system. It uses 3D imaging that helps with in depth perception for precision in surgery.

The on-going Covid-19 pandemic has burdened healthcare systems across the globe and has led to significant transformations in the healthcare industry, thereby forcing endoscopy facilities to reduce volumes of elective and non-essential endoscopic procedures. For instance, a survey conducted for endoscopy units across 55 countries by the World Endoscopy Organization between April 2020 and May 2020, reported an 87.0% reduction of in the number of endoscopy procedures. The ongoing pandemic has caused alterations in the operating room structures, workforce, indications, and pre-op setup. The alarming decline in endoscopic procedures was recorded in emerging economies with developing healthcare facilities.

In 2021, the reusable product type segment accounted for the largest revenue share owing to the widespread adoption of these products due to their recoverability rate through disinfection and sterilization. The bifurcation of these products based on the exposure of infection risk into critical, semi-critical, and non-critical devices enables selecting the appropriate disinfection process. On the other hand, single use product type segment is anticipated to register the fastest growth during the forecast period owing to the increasing incidence of hospital acquired infections due to reusable products. In addition, single use products are low on maintenance cost and storage, which is expected to propel the growth of this segment. Lastly, this product segment is witnessing a rise in adoption levels to curb the incidences of cross-contamination.

Based on the application, the decompression segment accounted for the highest revenue share in 2021 owing to its minimally invasive nature and enhanced visualization of discs and nerves is contributing to the growth of this segment. The various forms of decompression procedures provide more favorable outcomes and minimum complications, thereby boosting growth. In addition to decompression techniques available for varied indications, degenerative lumbar canal stenosis recorded the highest revenue share in 2021 owing to the multiple benefits of decompression procedures such as prevention of paraspinal muscle atrophy, reduced muscle dissection, and retraction.

Based on end-user, the hospitals segment accounted for the largest revenue share in 2021 owing to large-scale adoption of these endoscopic procedures and growing demand for minimally invasive surgeries. On the other hand, ambulatory surgery centers/clinics are anticipated to be the fastest growing segment during the forecast period owing to increasing preference for minimally invasive surgeries and reduced hospitalization. The growing trend of same day surgery has resulted in significant cost savings and optimum care delivery in the developed economies and is therefore expected to boost segment growth.

In 2021, North America dominated the market. This can be attributed to developed healthcare infrastructure, high adoption of advanced technologies, and an increase in awareness about the advantages of minimally invasive therapies. On the other hand, Asia Pacific is expected to be the fastest-growing region during the forecast period owing to increasing investments by market players for geographic expansion and rapid economic development in countries such as China and India and improving health infrastructure in this region. Moreover, the prevalence of spinal disorders in the geriatric population is the highest in this region due to the presence of largest proportion of the geriatric population.

Related Press Release@ Unilateral Biportal Endoscopy Market Report

Unilateral Biportal Endoscopy Market Report Highlights

The market size is anticipated to be valued at USD 1.3 billion by 2030, owing to increasing demand for minimally invasive surgeries and advancements in endoscopic visualization systems
The reusable product segment dominated the market in 2021 owing to the high recoverability rate with advanced disinfection and sterilization techniques
The decompression application segment dominated the market in 2021, owing to its minimal invasive nature and quicker recovery time
The hospital segment dominated the market in 2021 owing to large scale adoption of endoscopic procedures and catering to the rising demand of minimally invasive surgeries
North America dominated the market in 2021 owing to well-established healthcare facilities and technological advancements in endoscopic techniques

Thursday 18 August 2022

Aesthetic Medicine Market Size Worth $332.1 Billion By 2030

The global Aesthetic Medicine Market size is expected to reach USD 332.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.5% from 2022 to 2030. According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is a branch of medicine focused on satisfying the aesthetic desires and goals of patients. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Some key drivers of the market include the introduction of innovative aesthetic devices such as non-invasive aesthetic devices, a growing focus on physical appearance, and a rise in adoption among geriatric individuals.

Aesthetic medicine mainly includes invasive and non-invasive procedures. Invasive procedures include breast augmentation, liposuction, and nose reshaping while non-invasive procedures include popular technology such as Botox injections, soft tissue fillers, and chemical peel. The rise in the number of obesity cases in the U.S. has urged patients to opt for aesthetic treatments in the country. In the Asia Pacific region, the rise in the income level of the adult population in countries, such as China and India, is expected to create lucrative growth opportunities for the market. The region is also backed by South Korea, which is the hub of cosmetic surgeries.

The growing urge to look young and fit has increased the demand for aesthetic treatment in developing countries. Aesthetic procedures such as liposuction, nose reshaping, and Botox injections are gaining consumer interest in countries such as India and South Korea. Adults are paying attention to their physical appearance closely. This has increased the demand for cosmetic surgeries, with Botox being one of the most popular procedures preferred.

Related Press Release@ Aesthetic Medicine Market Report

Aesthetic Medicine Market Report Highlights

Based on procedure type, the non-invasive procedures segment dominated the market in 2021 and is projected to maintain its lead throughout the forecast period owing to its quick and accurate results, along with the ease of usage compared to invasive procedures
In the invasive procedures segment, breast augmentation and liposuction are expected to witness significant growth over the forecast period
The Asia Pacific region is projected to register the fastest CAGR of 10.9% during the forecast period. Countries such as South Korea and India are expected to serve as key revenue pockets

Tuesday 16 August 2022

U.S. Virtual Visits Market by American Well Corporation, MDLive, Inc, Doctor On Demand, Inc, eVisit Telemedicine Solution

The U.S. Virtual Visits Market size is expected to reach USD 105.5 billion in terms of revenue and 5.2 billion in terms of volume by the end of the forecast period and is expected to grow at a CAGR of 30.9% in terms of revenue, and 36.9% in terms of volume as per a new report published by Grand View Research, Inc. Increasing demand for telehealth and teleconsultation and introduction of new and advanced technologies has positively impacted the growth of the market in the U.S. Increasing penetration of smartphones and assisted technologies has also been a key factor for the fast growth of the market.

In the service segment, cold and flu management had the largest market share in 2021. The major factor behind the growth of the market is the growing demand for teleconsultations for patients for treatment of common conditions like cold and flu to reduce the chances of contracting additional illnesses due to hospital visits. The availability of specialists through telehealth and teleconsultations, even in remote areas has brought about a revolution in the virtual visits market, acting as a key factor for the growth of the market.

Based on age, the 18 to 34 years segment had the largest market share in 2021. The growth is a result of increasing smartphone penetration and increased internet usage by the consumers in this age group. The increase in the number of young adults suffering from mental health issues has also risen in the past few years and more so during COVID-19, resulting in a large market share.

Based on gender, women dominated the market with a revenue share of 65% in 2021. The increasing demand for telemedicine and telehealth had increased due to COVID-19 to reduce the chances of contracting additional infections, especially in pregnant females. The virtual visits made it easier for all to get access to specialists and better healthcare facilities within the comfort of their homes, proving to be a major factor in the growth of this segment and the market overall.

Based on the type of commercial plans, self-funded/ASO group plans had the largest revenue share. Growth in this segment has been a result of ASO groups proposing and encouraging virtual visits in their coverage plans to avoid regular visits to hospitals in avoidable conditions. During the pandemic, only non-emergency visits throughout the country were encouraged by healthcare providers to avoid the risk of infection. In wake of the pandemic, employers are increasingly preferring self-coverage plans and providing cost-effective healthcare services for their employees to diminish the exploding healthcare costs, which is further enhancing the growth of the market.

The COVID-19 pandemic created a massive growth spurt for the virtual visits market in the U.S. With the people needing healthcare solutions during the peak of the pandemic, teleconsultations were providing the necessary care that was needed. The huge jump in the uptake of virtual consultations was a result of government initiatives as well as fear of contracting the disease by physically visiting the hospitals. It came as a necessary relief for the healthcare providers as well, where they were less burdened due to the use of teleconsultations in case of non-emergency cases. The overall productivity of the healthcare system had also improved, proving the virtual visit market has been a great success and would be a way to consult in the future as well.

Related Press Release@ U.S.Virtual Visits Market Report

U.S. Virtual Visits Market Report Highlights

The U.S. market is expected to reach USD 105.5 billion (Revenue) and 5.2 billion visits (Volume) by 2030, due to rising demand for telehealth services and virtual visits and also due to advancements in the field of delivering virtual care through apps and connected devices
The cold and flu management service segment had the biggest revenue share as of 2021. Growing adoption rates of telehealth solutions to get consultations regarding common conditions have risen during the pandemic, this has been a result of awareness and encouragement by all private and government agencies to curb the spread of the disease
The age group 18-34 dominated, capturing the revenue share of 31.8% in 2021, this has been due to the increasing use of smartphones and internet-connected devices, increasing burden of mental health issues among the consumers in this age, and ease of access to healthcare through virtual visits, all contributing to the growth of the segment
In the gender segment, women dominated the market with a record revenue share of 65% in 2021. The increasing adoption of virtual visits during the pandemic had created a safe environment for pregnant women to receive the best healthcare without physically going to hospitals and quality post-natal care was also made available for women, resulting in the overall growth of the market

Wednesday 10 August 2022

Cancer Diagnostics Market Worth $249.6 Billion By 2026 | CAGR: 7.0%

The global Cancer Diagnostics Market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Further key findings from the report suggest:

Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of imaging systems. Thus, the segment is expected to exhibit the fastest CAGR at 8.0% during the forecast period
The breast cancer segment accounted for the largest share based on application due to high incidence rate of breast cancer triggering the need for its early diagnosis
In 2018, North America dominated the global space with the largest revenue share of 42.0%. Focused research efforts in oncology for development of early tumor detection tools, coupled with grants from government healthcare agencies, are contributing to a strong medical ecosystem to fight cancer in this region
Asia Pacific is expected to emerge as the fastest growing region during the forecast period. Favorable regulatory framework and growing patient pool in India, China, and Japan due to support in diagnostic process at comparatively lower prices are some of the factors boosting the market growth in this region
Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd.; and Siemens Healthcare GmbH. Other prominent players include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc.